We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biological Coating Halts Bleeding on Contact

By HospiMedica International staff writers
Posted on 30 Jan 2012
A nanoscale biological coating halts bleeding nearly instantaneously, an advance that could dramatically reduce battlefield deaths.

Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, USA) and Ferrosan Medical Devices (Ferrosan; Soeborg, Denmark) developed a nanoscale biological coating that consists of alternating layers of thrombin--a natural clotting protein--and tannic acid. More...
The combination yields a biological film containing large amounts of functional thrombin that when sprayed onto a material, such as a sponge, can be used as a battlefield dressing. A key advantage of the spray method is that it allows a large amount of thrombin to be packed into the sponges, coating even the interior fibers. Once sprayed, the sponges can be molded to fit the shape of any wound and subsequently be stored for months before use.

In laboratory tests conducted at Ferrosan using a porcine spleen bleeding model, the coated sponges were applied to wounds with light pressure (from a human thumb), for 60 seconds, and stopped the bleeding within that time frame; sponges lacking thrombin required at least 150 seconds to stop the bleeding. For comparison, a simple gauze patch, applied for 12 minutes (the length of the experiment), failed stop bleeding. The researchers have filed a patent application on the technology, as well as on similar sponges coated with the antibiotic vancomycin. They are now working on combining the blood-clotting and antibiotic activities in a single sponge. The study describing the technology and the test results was published on December 27, 2011, in the online edition of Advanced Materials.

“Now we have an alternative that could be used without applying a large amount of pressure and can conform to a variety of wounds, because the sponges are so malleable,” said lead author Anita Shukla, PhD, of MIT. “Both materials are already approved by the US Food and Drug Administration, which could help with the approval process for a commercialized version of the sponges.”

Traditional methods to halt bleeding at the battlefield, such as tourniquets, are not suitable for the neck and many other parts of the body, causing researchers to try alternative approaches, all of which have disadvantages. Fibrin dressings and glues have a short shelf life, can cause an adverse immune response, while zeolite powders are difficult to apply under windy conditions, and can cause severe burns. Another option is bandages made of chitosan, a derivative of the primary structural material of shellfish exoskeletons. Those bandages have had some success but can be difficult to mold to fit complex wounds.

Related Links:

Massachusetts Institute of Technology
Ferrosan Medical Devices




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.